BioNTech SE - ADR

NASDAQ:BNTX  
247.69
-2.64 (-1.06%)
Products

Pfizer Says Co And Biontech Officially Submitted Request To FDA For Authorization Of COVID-19 Vaccine In Children 5 To <12 - Tweet

Published: 10/07/2021 12:31 GMT
BioNTech SE - ADR (BNTX) - Pfizer Says Co and Biontech Officially Submitted Request to FDA for Emergency Use Authorization of Our Covid19 Vaccine in Children 5 to